Literature DB >> 32170346

Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT.

P Mapelli1,2, F Fallanca2, A Franchini2,3, L Albarello4, E G Vanoli2, S Partelli1,5, F Muffatti5, L Gianolli2, M Falconi1,5, M Picchio6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32170346     DOI： 10.1007/s00259-020-04719-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.

Authors:  Aaron T Scott; Daniel Pelletier; Jessica E Maxwell; Scott K Sherman; Kendall J Keck; Guiying Li; Joseph S Dillon; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe
Journal:  Ann Surg Oncol       Date:  2019-04-22       Impact factor: 5.344

Review 2.  68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis.

Authors:  Michael M Graham; Xiaomei Gu; Timothy Ginader; Patrick Breheny; John J Sunderland
Journal:  J Nucl Med       Date:  2017-03-09       Impact factor: 10.057

Review 3.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

4.  Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.

Authors:  Harun Ilhan; Wolfgang P Fendler; Clemens C Cyran; Christine Spitzweg; Christoph J Auernhammer; Franz-Josef Gildehaus; Peter Bartenstein; Martin K Angele; Alexander R Haug
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

5.  Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.

Authors:  Amitabh Srivastava; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

6.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.